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ABSTRACT 
Schisandrae Fructus, the fruit of Schisandra chinensis (Turcz.) Baill., is widely used in traditional medicine for 
the treatment of a number of chronic diseases. Although, Schisandrae Fructus was recently reported to attenuate 
the interleukin (IL)-1β-induced inflammatory response in chondrocytes in vitro, its protective and therapeutic po-
tential against osteoarthritis (OA) in an animal model remains unclear. Therefore, we investigated the effects of 
the ethanol extract of Schisandrae Fructus (SF) on inflammatory responses and cartilage degradation in a mono-
sodium iodoacetate (MIA)-induced OA rat model. Our results demonstrated that administration with SF had a 
tendency to attenuate MIA-induced damage of articular cartilage as determined by a histological grade of OA. SF 
significantly suppressed the production of pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor 
necrosis factor-α in MIA-induced OA rats. SF also effectively inhibited expression of inducible nitric oxide (NO) 
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synthase and cyclooxygenase-2, thereby inhibiting the release of NO and prostaglandin E2. In addition, the elevated 
levels of matrix metalloproteinases-13 and two biomarkers for diagnosis and progression of OA, such as cartilage 
oligomeric matrix protein and C-telopeptide of type II collagen, were markedly ameliorated by SF administration. 
These findings indicate that SF could be a potential candidate for the treatment of OA.  
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INTRODUCTION 
Osteoarthritis (OA) is the most common 
musculoskeletal disease causing chronic pain 
and joint disability. OA is characterized by 
the loss of articular cartilage, involving in-
creased subchondral bone remodeling, osteo-
phyte formation, weakening of the periarticu-
lar muscles, and thickening of the capsule and 
synovial membrane, which lead to functional 
joint limitations (Guilak, 2011; Mobasheri, 
2013; Speziali et al., 2015). In particular, OA 
is the result of mechanical and biological 
events that cause the degradation of articular 
cartilage. These processes are mediated by 
excessive synthesis and release of catabolic 
tissue proteinases, such as matrix metallopro-
teinases (MMPs), collagenases and aggre-
canases, that are upregulated by inflammatory 
stimuli and oxidative stress, including inflam-
matory cytokines and mediators, and reactive 
oxygen species (Goldring and Otero, 2011; 
Makki and Haqqi, 2015; Lepetsos and Papa-
vassiliou, 2016). Currently, pharmacological 
treatment for patients with OA is based on 
some steroidal and non-steroidal anti-inflam-
matory drugs for alleviation of pain as well as 
inflammation. However, they can not per-
fectly prevent the progressive cartilage degra-
dation and repair the impaired cartilage of OA 
patients, and long-term use of these drugs can 
lead to severe side effects or toxicity, includ-
ing gastrointestinal disturbances and cardio-
vascular risk (Mobasheri, 2013; Goldring and 
Berenbaum, 2015). Therefore, ideal agents 
that inhibit cartilage degradation with better 
safety and efficacy may represent an attrac-
tive strategy to treat OA. 
Herbal sources have been widely and 
safely consumed for centuries. Many studies 
indicate that these herbs have a wide range of 
diverse biological activities with few side ef-
fects (Chen et al., 2015; Hou et al., 2015). 
Therefore, traditional herbal medicinal 
sources have been investigated widely as ad-
juvant therapeutic agents in the treatment of 
OA (Cameron and Chrubasik, 2013; Dhip-
payom et al., 2015). Schisandrae Fructus, the 
dried fruit of Schisandra chinensis (Turcz.) 
Baill. (Magnoliaceae), has been used in tradi-
tional medicine for the treatment of various 
medicinal purposes (Panossian and Wikman, 
2008; Chun et al., 2014). The diverse pharma-
cological effects of Schisandrae Fructus in-
clude antioxidant (Kang et al., 2014a), anti-
tumor (Lv et al., 2015), hepatoprotective (Wat 
et al., 2016), anti-septic (Kook et al., 2015), 
neuroprotective (Lee et al., 2012), anti-in-
flammatory (Bae et al., 2012; Kang et al., 
2014b), anti-atherosclerotic (Jeong et al., 
2015a), and anti-atrophic (Kim et al., 2015a, 
b), and anti-diabetic effects (Kwon et al., 
2011). Recently we reported that Schisandrae 
Fructus possessed potential chondroprotec-
tive effects of the collagen matrix breakdown 
in a pro-inflammatory cytokine interleukin 
(IL)-1β-induced model in vitro (Jeong et al., 
2015b). However, to our knowledge, the in 
vivo therapeutic effects of this compound and 
its effects on the molecular mechanisms of 
OA have not been investigated. Therefore, as 
a part of our on-going research program for 
finding novel anti-osteoarthritic substances 
from traditional medicinal sources, the pre-
sent study investigated the anti-osteoarthritic 
potential and underlying mechanism of an 
ethanol extract of Schisandrae Fructus (SF) in 
a rat model of metabolic-inhibitor-monoso-
dium iodoacetate (MIA)-induced OA. 
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MATERIALS AND METHODS 
Preparation of SF 
The dried fruits of S. chinensis were col-
lected from Mungyeong city (Gyeongsang-
buk-do, Republic of Korea) and washed three 
times with tap water before storage at -80 °C. 
Frozen samples were lyophilized and homog-
enized using a grinder before extraction with 
20 % ethanol at room temperature for 4 h, fil-
tered, and concentrated using a rotary vacuum 
evaporator (BÜCHI Labortechnik, Flawil, 
Switzerland). The extract (SF) was dissolved 
in dimethyl sulfoxide (DMSO; Sigma-Al-
drich Chemical Co., St. Louis, MO, USA) as 
a 50 mg/mL stock solution and stored at 4 °C 
and diluted with physiological saline to the 
desired concentration prior to use. 
 
Animals 
Male Sprague-Dawley rats weighing 
180~240 g (5 weeks of age) at the start of the 
experiment were purchased from Samtako 
Inc. (Osan, Republic of Korea). Two animals 
were housed per polycarbonate cage in a 
room under controlled-temperature condi-
tions (20~24 °C, humidity 40~70 %) with 
controlled lighting (12 h light and/or 12 h dark 
cycle) and had access to sterile food and R/O 
water (Lee et al., 2016). This study was car-
ried out in strict accordance with the recom-
mendations of the Guide for the Care and Use 
of Laboratory Animals of the National Insti-
tutes of Health. In addition, the animal proto-
col used in this study was reviewed by the 
Dongeui University - Institutional Animal 
Care and Use Committee on their ethical pro-
cedures and scientific care, and it has been ap-
proved (Approval Number: A2015-019).  
 
Development of OA with MIA injection and 
administration with SF 
The rats were randomized and assigned to 
treatment groups before the initiation of the 
study (n = 8 per group). For induction of OA, 
rats were anesthetized using isoflurane and 
then given a single injection of 50 μL sterile 
0.9 % saline containing 3 mg/kg MIA 
(Sigma-Aldrich Chemical Co.) using a 
0.3 mL insulin syringe (BD Medical-Diabetes 
Care, Franklin Lakes, NJ, USA) through the 
patellar ligament into the articular cavity of 
the right knee. Control rats were injected with 
an equivalent volume of saline. SF was ad-
ministered orally once per day for 3 weeks at 
a dose of 100 mg/kg. 
 
Measurement of knee joint swelling 
After the rats were killed at 3 weeks post-
MIA injection, the right knee was isolated, 
and the femur, tibia, and patella were dis-
sected free of muscle. Knee diameter was 
measured using a calibrated digital caliper 
(Mitutoyo, Kawasaki, Japan) to assess the de-
velopmental stages of OA on 3 weeks post-
MIA injection (Fernihough et al., 2004). 
 
Serum analysis 
At the end of the 3 weeks, the samples of 
whole blood were collected from the ab-
dominal vein. Blood was allowed to clot for 
30 min. Then, the serum was separated via 
centrifugation at 1,500 g for 10 min and 
stored at -80 °C. Concentrations of nitric ox-
ide (NO) in the serum samples were deter-
mined by measuring nitrite, which is a major 
stable product of NO, using the Griess rea-
gent. Briefly, 50 μL of serums were mixed 
with 50 μL of Griess reagent (Sigma-Aldrich 
Chemical Co.), followed by incubation for 10 
min at 37 °C. Optical density was measured at 
540 nm using an enzyme-linked immuno-
sorbent assay (ELISA) reader (Dynatech La-
boratories, Chantilly, VA, USA) (Kwon et al., 
2016). Serum levels of prostaglandin E2 
(PGE2) were determined according to the 
manufacturer’s instructions (ELISA kit, R&D 
Systems, Minneapolis, MN, USA) (Kim et 
al., 2016). The pro-inflammatory cytokines 
including IL-1β, IL-6 and TNF-α, and carti-
lage degeneration mediators such as cartilage 
oligomeric matrix protein (COMP) and C-
telopeptide of type II collagen (CTX-II) were 
also determined using ELISA kits (R&D Sys-
tems, Minneapolis, MN, USA) according to 
the manufacturer’s recommendations.  
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Joint histological examination 
Histological changes were assessed to 
confirm the effects of SF on cartilage degen-
eration in the knee joints of MIA-induced OA 
rats. After the rat sacrifice at 3 weeks, each 
knee joint was resected, fixed in 10 % forma-
lin (Sigma-Aldrich Chemical Co.) for 24 h at 
4° C, and decalcified with 5 % hydrochloric 
acid (Sigma-Aldrich Chemical Co.) for 4 days 
at 4° C. After decalcification, the specimens 
were embedded in paraffin. Sections (2~3 
μm) were stained with hematoxylin and eosin 
(H&E), safranin O-fast green and toluidine 
blue (Sigma-Aldrich Chemical Co.), respec-
tively, and then observed under Carl Zeiss 
Axio-plan 2 imaging microscope (Carl Zeiss, 
Deisenhofen, Germany). All stained slides 
were histologically evaluated and statistically 
graded on a scale of 0~13 by double-blind ob-
servation, according to the modified Mankin 
scoring system (Mankin et al., 1971). 
 
Immunohistochemical analysis 
The sections were depleted of endogenous 
peroxidase activity by treatment with 3 % 
H2O2 for 15 min. They were then were 
blocked with normal goat serum (Sigma-Al-
drich Chemical Co.) for 30 min and incubated 
at 4 °C overnight with primary antibodies fol-
lowed by the appropriate biotinylated second-
ary antibodies and horseradish peroxidase-
conjugated streptavidin-biotin staining, and 
finally with a 3,3′-diaminobenzidine (DAKO, 
Glostrup, Denmark). Primary antibodies 
against the following proteins were used: in-
ducible NO synthase (iNOS, 1:100; SC-7271, 
mouse monoclonal, Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA, USA), cyclooxy-
genase-2 (COX-2, 1:50; SC-19999, mouse 
monoclonal; Santa Cruz Biotechnology, Inc.), 
MMP-13 (1:50; ab51072, rabbit monoclonal; 
Abcam, Cambridge, UK), COMP (1:50; 
ab11056, rabbit monoclonal; Abcam) and 
CTX-II (1:50; PAA686Hu01, rabbit polyclo-
nal; Cloud-Clone Corp., Houston, TX, USA ). 
Histological changes were examined by a 
Carl Zeiss Axio-plan 2 imaging microscope 
(Carl Zeiss) and photographed. 
 
Statistical analysis 
Data were expressed as mean ± standard 
deviation (SD) for at least three separate de-
terminations for each group. The differences 
between the groups were examined for statis-
tical significance using the Student’s t-test 
and one-way ANOVA with GraphPad soft-
ware (GraphPad Inc., La Jolla, CA, USA). A 
value of p < 0.05 was considered as being sig-
nificant. 
 
RESULTS 
SF reduced MIA-induced knee swelling in 
rats 
Knee diameters were measured to deter-
mine the degree of joint swelling, an index of 
inflammation that occurred after intra-articu-
lar injection of MIA. As shown in Figure 1, 
the knee diameter of in MIA groups increased 
significantly after an intra-articular injection 
of MIA as compared with normal control 
group. However, SF treatment significantly 
reduced the joint swelling at 3 weeks after 
MIA injection. 
 
SF ameliorated the histological evaluation 
of the articular damage in MIA-induced 
OA rats 
Because, the cartilage degeneration is the 
main histologic feature of OA, we investi-
gated the effects of SF on the morphological 
changes and severity of the particular damage 
using H&E, Safranin O-fast green, and tolui-
dine blue staining in the MIA-induced OA rat. 
Our findings showed that MIA-injected group 
showed the severity of surface irregularity 
and surface cleft, and matrix loss of articular 
cartilage associated (Figure 2A). However, 
SF alone had little effect on the structural, 
morphological changes in the joints, and ad-
ministration with SF attenuated damages in 
the articular cartilages compared with those of 
the MIA-treated group. Therefore, the sever-
ity of OA lesion was graded using the modi-
fied Mankin scoring system, and we found 
that the overall modified Mankin’s scores 
were significantly recovered by SF treatment 
compared with a MIA-treated group (Figure 
2B). 
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Figure 1: Effects of SF on knee joint swelling in MIA-induced OA rats. (A) Photographs of the hind knee 
joint at 3 weeks after the model of MIA-induced OA rats. (B) The severity of osteoarthritis during the 
course of MIA was determined by measuring the volume of the hind knee joint using calibrated digital 
caliper. Data were expressed as mean ± SD (n = 8) (**p < 0.01 MIA group vs. control group;  
###p < 0.001 SF+MIA treatment groups vs. MIA group) 
 
 
 
Figure 2: Histological evaluation of joints activity after administration with SF in MIA-induced OA rats. 
Rats were injected with 3 mg MIA in the right knee. SF was administered orally daily for 3 weeks after 
MIA injection. (A) The knee joints of OA rats treated with either SF or vehicle control were stained with 
H&E, Safranin O and toluidine blue. (B) The joint lesions were graded on a scale of 0–13 using the 
modified Mankin scoring system, giving a combined score for cartilage structure, cellular abnormalities, 
and matrix staining. Data were expressed as mean ± SD (n = 8) (*p < 0.05 MIA group vs. normal control 
group; #p < 0.05 SF+MIA treatment groups vs. MIA group) 
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SF inhibited the production of pro-inflam-
matory cytokines in MIA-induced OA rats 
Pro-inflammatory cytokines have im-
portant roles in the development and progres-
sion of OA (Kapoor et al., 2011; Mabey and 
Honsawek, 2015). We, therefore, determined 
whether SF had any inhibitory effects on the 
production of inflammatory cytokines associ-
ated with OA, such as IL-1β, IL-6, and TNF-
α. As illustrated in Figure 3, the serum levels 
of the cytokines significantly increased in the 
serum of MIA group compared with those in 
the saline group; however, the group treated 
with SF effectively inhibited the production 
of IL-1β, IL-6, and TNF-α when compared to 
MIA alone.  
 
SF protected the production on NO and 
PGE2, and expression of iNOS and COX-2 
in MIA-induced OA rats 
Because overproductions of pro-inflam-
matory mediators such as NO and PGE2 also 
have been correlated to the pathophysiology 
of OA (Amin et al., 2000; Martel-Pelletier et 
al., 2003), we investigated the effects of SF on 
NO and PGE2 release in MIA-induced OA 
rats. As indicated in Figure 4A and B, a sub-
stantial increase in the NO and PGE2 levels 
were detected in MIA-induced OA rats when 
compared to normal control group; however, 
these levels were significantly decreased fol-
lowing SF administration. We subsequently 
investigated whether the inhibitory effects of 
SF on NO and PGE2 production were related 
to the regulation of the expression of their 
synthesis enzymes, iNOS, and COX-2, in 
knee joints by immunohistochemical analy-
sis. The results showed that compared to the 
control group, MIA remarkably induced the 
expression of iNOS and COX-2, while, SF 
obviously suppressed elevated expression 
levels of iNOS and COX-2 in the cartilagi-
nous tissues of the MIA-induced OA rats 
(Figure 4C and D).  
 
 
 
Figure 3: Effects of SF on the cytokines (IL-1β, IL-6, and TNF-α) production in the serum of MIA-induced 
OA rats. Rats were injected with 3 mg MIA in the right knee. SF was administered orally daily for 3 
weeks after MIA injection. (A) The concentrations of IL-1β, (B) IL-6 and (C) TNF-α in serum collected 
from MIA-induced OA rats treated with or without SF. Data were expressed as mean ± SD (n = 8) (*p < 
0.05 and **p < 0.01 MIA group vs. normal control group; #p < 0.05 and ##p < 0.01 SF+MIA treatment 
groups vs. MIA group) 
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Figure 4: Effects of SF on the production of NO and PGE2, and expression of iNOS and COX-2 in MIA-
induced OA rats. The contents of NO (A) and PGE2 (B) were measured in the serum of MIA-induced 
OA rat using Griess reaction and commercial ELISA kit, respectively. (C and D) Immunohistochemical 
staining was used to identify the expression of iNOS and COX-2 in the articular cartilage. Data were 
expressed as mean ± SD (n = 8) (*p < 0.05 MIA group vs. normal control group;  
**p < 0.01 MIA group vs. normal control group; #p < 0.05 SF+MIA treatment groups vs. MIA group;  
##p < 0.01 SF+MIA treatment groups vs. MIA group) 
 
 
SF down-regulated the MMP-13 expres-
sions in MIA-induced OA rats 
The progressive destruction of cartilage 
degradation in OA is caused by several ma-
trix-degrading enzymes including MMPs pro-
duced by the chondrocytes and synovium 
(Burrage et al., 2006; Troeberg and Nagase, 
2012). Because, among the MMPs family, 
MMP-13 play a most important role in de-
grading cartilage (Takaishi et al., 2008; Li et 
al., 2011), we examined the effects of SF on 
the expression of MMP-13 in MIA-stimulated 
OA cartilage. Our results demonstrated that 
the number of chondrocytes staining positive 
for MMP-13 was increased after MIA injec-
tion, with significantly lower percentages of 
MMP-13-positive chondrocytes evident in 
the SF-administered group relative to saline-
treated controls (Figure 5). 
SF diminished the production of COMP 
and CTX-II in MIA-induced OA rats 
We next investigated the effects of SF on 
the levels of COMP and CTX-II, well-estab-
lished biomarkers for diagnosis and OA pro-
gression (Goode et al., 2012; Saberi Hosnijeh 
et al., 2016), which play key roles during sub-
sequent progressive osteophytes in multiple 
knee compartments. Our ELISA data indi-
cated that excessive production of COMP and 
CTX-II were evident in the serum of MIA-in-
duced OA rats; these levels were significantly 
diminished following SF administration (Fig-
ure 6A and B). Consistent with the results of 
ELISA, immunohistochemistry assay showed 
that oral administration with SF caused a sig-
nificant decrease in expression of COMP as 
well as CTX-II compared with that in the nor-
mal control group (Figure 6C and D). 
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Figure 5: Effects of SF on the expression of MMP-13 in MIA-induced OA rats. (A) The immunohisto-
chemical staining was used to identify the expression of MMP13 in the articular cartilage. (B) Data were 
expressed as mean ± SD (n = 8) (*p < 0.05 MIA group vs. normal control group; #p < 0.05 SF+MIA 
treatment groups vs. MIA group) 
 
 
Figure 6: Effects of SF on production and expression of COMP and CTX-Ⅱ in MIA-induced OA rats. (A 
and B) The COMP and CTX-II production were measured in the serum of MIA-induced OA rat using a 
commercial ELISA kits. (C and D) Immunohistochemical staining was used to identify the expression of 
COMP and CTX-II in the articular cartilage. Data were expressed as mean ± SD (n = 8)  
(*p < 0.05 MIA group vs. normal control group; **p < 0.01 MIA group vs. normal control group;  
#p < 0.05 SF+MIA treatment groups vs. MIA group) 
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DISCUSSION 
In this study, we investigated whether or 
not SF exerts a chondroprotective effect in a 
rat OA model by injection with MIA, which 
is known to induce OA through interruption 
of chondrocyte metabolism (Barve et al., 
2007). Our data showed that oral administra-
tion of SF led to a significant decrease of 
structural changes such as joint space narrow-
ing and cartilage destruction in MIA-induced 
OA rats, which was associated with a reduc-
tion of pro-inflammatory molecules, MMP-
13 and both biomarkers of cartilage and bone 
metabolism such as COMP and CTX-II.  
The compelling evidence demonstrated 
that pro-inflammatory cytokines are signifi-
cantly elevated in synovial fluid from OA pa-
tients and play critical roles in the promotion 
of the catabolic processes in OA, causing car-
tilage degradation (Kapoor et al., 2011; Rah-
mati et al., 2016). High levels of pro-inflam-
matory cytokines have been found in synovial 
fluid from OA patients and several models of 
cartilage degradation (Goldring and Otero, 
2011; Kellesarian et al., 2016). Among these 
cytokines, IL-1β is highly over-expressed in 
the cartilage as well as in the synovial tissue 
while the expression of IL-1Rα, a receptor an-
tagonist of the IL-1 family (Jotanovic et al., 
2012). This cytokine inhibits proliferation and 
triggers apoptosis of chondrocytes and blocks 
the extracellular matrix (ECM) structural 
compounds synthesis by activating MMPs in-
cluding MMP-13 (Mabey and Honsawek, 
2015; Rahmati et al., 2016). IL-6 has also 
been reported to act as one of the main pro-
inflammatory cytokines involved in the path-
ophysiology of OA. IL-6 induces destruction 
of joint and cartilage by stimulating the acti-
vation of osteoclasts and differentiation of 
mesenchymal cells into chondroblasts (Doss 
et al., 2007; Jotanovic et al., 2012). In addi-
tion, previous studies revealed that TNF-α has 
similar to or synergistic with IL-1β and IL-6 
in the production of matrix-degrading en-
zymes and inhibition of proteoglycan synthe-
sis, resulting in loss of cartilage and bone re-
sorption during the process of OA develop-
ment (Jotanovic et al., 2012; Kellesarian et 
al., 2016). In accordance with, many studies 
demonstrated that anti-inflammatory agents 
capable of inhibiting the production of those 
cytokines may have the potential to control or 
treatment of OA (Kapoor et al., 2011; Mabey 
and Honsawek, 2015). Hence, we investi-
gated the anti-inflammatory effects of SF by 
measurements of the serum levels of pro-in-
flammatory cytokines, such as IL-1β, IL-6, 
and TNF-α, in MIA-induced OA rats, and 
found that SF administration decreased these 
cytokines, the MIA increased these parame-
ters. Taken together, the present results indi-
cate that SF has a potential of prevention 
against inflammatory responses, and subse-
quently might reduce the damage of articular 
cartilage. 
In addition to the roles of inflammatory 
cytokines, pro-inflammatory mediators such 
as NO and PEG2 plays an extremely im-
portant role in the development of inflamma-
tion in OA (Amin et al., 2000; Rahmati et al., 
2016). These pro-inflammatory mediators can 
induce cell death of chondrocytes and loss of 
cartilage matrix in the pathogenesis of OA, 
and they are also significantly elevated in car-
tilage and synovial tissues from OA patients 
(Notoya et al., 2000; Park et al., 2006). More-
over, the pro-inflammatory cytokines can 
stimulate the production of pro-inflammatory 
mediators, such as NO and PEG2, through ac-
tivation of chondrocytes (Martel-Pelletier et 
al., 2006; Rahmati et al., 2016). Therefore, we 
next investigated the effects of SF on the re-
lease of NO and PEG2 in MIA-induced OA rat 
model. Our results clearly demonstrated that 
the serum levels of NO and PEG2 were signif-
icantly higher in the MIA group compared 
with the control group. However, SF effec-
tively reduced MIA-induced elevation of NO 
and PEG2 production by suppressing up-
stream molecules iNOS and COX-2 expres-
sion, consistent with a previous our report that 
SF reduced production of NO and PEG2 in IL-
1β-stimulated human chondrocytes (Jeong et 
al., 2015b) and lipopolysaccharide-activated 
murine macrophage (Kang et al., 2014b).  
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Accumulated evidence suggested that 
MMPs are important metalloproteases in-
volved in tissue remodeling including the 
turnover, catabolism, and degradation of the 
ECM (Burrage et al., 2006; Troeberg and Na-
gase, 2012). MMPs expression could be up-
regulated by pro-inflammatory cytokines in a 
variety of tissues and cell types, including ar-
ticular chondrocytes (Goldring and Otero, 
2011; Takaishi et al., 2008). Among the 
MMPs, MMP-13 is critical for degrading col-
lagens, proteoglycans and other ECM macro-
molecules in the osteoarthritic pathological 
process (Takaishi et al., 2008; Li et al., 2011). 
We then analyzed the expression of MMP-13, 
to assess the effects of SF on the catabolic ac-
tivity of chondrocytes. Consistent with previ-
ous studies (Andereya et al., 2006; Barve et 
al., 2007), the serum levels of MMP-13 and 
the percentages of MMP-13-positive chon-
drocytes were significantly higher in the 
MIA-treated group than in the saline-treated 
controls. However, our results demonstrated 
that the SF-administrated rats had fewer 
MMP-13-producing cells than did the MIA-
treated rats, which was connected with lower-
ing MMP-13 production. These observations 
support the fact that SF might have a chondro-
protective effect by reducing the production 
and activation of MMP-13. 
Several clinical studies in OA patients and 
OA animal models demonstrated that the ele-
vated levels of COMP and CTX-II are corre-
lated with increased risk and progression of 
OA. COMP, a pentameric glycoprotein, is 
one of the essential components of the extra-
cellular matrix of the cartilage (Goode et al., 
2012; Saberi Hosnijeh et al., 2016). COMP 
functions as a regulator in governing the as-
sembly of type II collagen fibers in cartilage, 
thereby this glycoprotein stabilizes the colla-
gen network in cooperation with other matrix 
proteins (Christgau et al., 2001). However, its 
levels during the development of OA and un-
der inflammatory condition are obviously in-
creased in serum and synovial fluid and posi-
tively correlated with joint damage in knee 
OA (Vilím et al., 2002; Verma and Dalal, 
2013). In addition, CTX-II is produced by 
degradation of type II collagen through the 
action of proteases with cartilage injury or de-
generation and finally excreted in the urine 
(Christgau et al., 2001; Freeston et al., 2011). 
CTX-II contents were also elevated in OA pa-
tients as compared with normal individuals, 
which levels are associated with both the 
prevalence and progression of OA (Jansen et 
al., 2009; Freeston et al., 2011). These obser-
vations indicated that these two factors have 
the potential to be prognostic biomarkers for 
monitoring cartilage degradation in patients 
with OA (Goode et al., 2012; Saberi Hosnijeh 
et al., 2016). In our ELISA study, both serum 
COMP and CTX-II levels in the MIA-induced 
OA group were highly increased compared to 
the control group; however, treatment with SF 
significantly prevented the increase. In agree-
ment with the result, the immunohistochemis-
try data also showed that rats injected with 
MIA dramatically increased COMP and 
CTX-II expression in articular cartilage, and 
besides administration with SF significantly 
reduced their expression in MIA-induced OA 
rats. Therefore, it is possible that the reduc-
tion in COMP and CTX-II serum levels by SF 
most likely represents suppressed MIA-in-
duced degradation of cartilage, as cartilage is 
a major contributor to circulating COMP and 
CTX-II levels. 
 
CONCLUSIONS 
In conclusion, we demonstrated that ad-
ministration with SF effectively attenuated 
the severity of articular cartilage destruction 
in MIA-induced OA of the knee joint in rats. 
To the best of our knowledge, this is the first 
report to demonstrate the antiarthritic effects 
of SF on MIA-induced OA model. The anti-
arthritic effects of SF were associated with the 
decreased production of pro-inflammatory 
cytokines, such as IL-1β, IL-6 and TNF-α, 
and mediators including NO and PGE2 
through reducing their corresponding genes 
expression. SF also protected the articular 
cartilage damage by suppression of MMP-13 
and two representative biomarkers for diag-
nosis of OA, COMP, and CTX-II, in the OA 
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animal model induced by MIA. Based on the 
results of this study, we suggest that Schisan-
drae Fructus has excellent potential as a ther-
apeutic modality for treating OA.  
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